NexImmune, Inc. (NASDAQ:NEXI – Get Free Report)’s stock price dropped 3.8% during trading on Wednesday . The stock traded as low as $0.93 and last traded at $0.93. Approximately 222 shares traded hands during mid-day trading, a decline of 100% from the average daily volume of 1,094,310 shares. The stock had previously closed at $0.97.
NexImmune Price Performance
The company’s 50 day simple moving average is $1.96 and its 200 day simple moving average is $3.95. The firm has a market cap of $1.28 million, a price-to-earnings ratio of -0.04 and a beta of 1.90.
NexImmune (NASDAQ:NEXI – Get Free Report) last posted its quarterly earnings results on Monday, May 20th. The company reported ($2.21) EPS for the quarter.
NexImmune Company Profile
NexImmune, Inc, a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform.
Recommended Stories
- Five stocks we like better than NexImmune
- There Are Different Types of Stock To Invest In
- Target Hits the Mark: Q2 Earnings Exceed Expectations
- Investing In Automotive Stocks
- Is Tesla’s Rebound Just Starting? Why You Should Consider Buying
- What is a Dividend King?
- Stanley Druckenmiller’s Latest Bet: MELI—Should You Follow Suit?
Receive News & Ratings for NexImmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NexImmune and related companies with MarketBeat.com's FREE daily email newsletter.
